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DHAApolipoprotein E (APOE) genotype is believed to play an important role in cardiovascular risk. APOE4 car-
riers have been associated with higher blood lipid levels and a more pro-inﬂammatory state compared
with APOE3/E3 individuals. Although dietary fat composition has been considered to modulate the
inﬂammatory state in humans, very little is known about how APOE genotype can impact on this
response. In a follow-up to the main SATgene study, we aimed to explore the effects of APOE genotype,
as well as, dietary fat manipulation on ex vivo cytokine production. Blood samples were collected from a
subset of SATgene participants (n = 52/88), prospectively recruited according to APOE genotype (n = 26
E3/E3 and n = 26 E3/E4) after low-fat (LF), high saturated fat (HSF) and HSF with 3.45 g docosahexaenoic
acid (DHA) dietary periods (each diet eight weeks in duration assigned in the same order) for the mea-
surement of ex vivo cytokine production using whole blood culture (WBC). Concentrations of IL-1beta,
IL-6, IL-8, IL-10 and TNF-alpha were measured in WBC supernatant samples after stimulation for 24 h
with either 0.05 or 1 lg/ml of bacterial lipopolysaccharide (LPS). Cytokine levels were not inﬂuenced
by genotype, whereas, dietary fat manipulation had a signiﬁcant impact on TNF-a and IL-10 production;
TNF-a concentration was higher after consumption of the HSF diet compared with baseline and the LF
diet (P < 0.05), whereas, IL-10 concentration was higher after the LF diet compared with baseline
(P < 0.05). In conclusion, our study has revealed the amount and type of dietary fat can signiﬁcantly mod-
ulate the production of TNF-a and IL-10 by ex vivo LPS-stimulated WBC samples obtained from normol-
ipidaemic subjects.
 2014 The Authors. Published by Elsevier Ltd. All rights reserved.1. IntroductionThe aetiology and progression of cardiovascular disease (CVD) is
affected by both environmental and genetic factors [1]. The most
widely researched common gene variants, with respect to CVD risk
are the apolipoprotein E (APOE) single nucleotide polymorphisms
(SNP) [2]. Although the literature is not fully consistent [3,4] APOE4
carriers (approximately 25% of the Caucasian population), have
been reported to have a higher risk of CVD. This was originally
attributed to elevated blood lipid levels in this subgroup [4]. How-
ever, the mechanisms that relate APOE4 to increased CVD risk may
be more complex than solely a lipid effect [1,2] with studies largely
conducted in transgenic animals or cell lines indicating that the
APOE4 allele is related to a more pro-oxidative and pro-inﬂamma-
tory state compared with the APOE3 allele [1,2].
Dietary fat manipulation may play an important role in the
inﬂammatory response [5,6]; several studies indicated increasing
levels of pro-inﬂammatory cytokines after a high fat meal or
A. Koutsos et al. / Cytokine 66 (2014) 156–159 157chronic consumption of a high fat diet [5,7,8]. However, few stud-
ies have focused on the impact of dietary fat composition on these
markers in response to iso-energetic diets. Recently, we have re-
ported that APOE genotype inﬂuences the C-reactive protein
(CRP) response to dietary fat intake, with higher concentrations
after diets rich in saturated fat (HSF) and HSF with 3.45 g/d of
docosahexaenoic acid (DHA) in APOE4 carriers, relative to a low
fat (LF) diet [9]. Yet, there are no studies investigating the com-
bined effect of APOE genotype and fat manipulation on cytokine
production in normolipidaemic subjects.
The aim of the present study was to investigate the effect of
these three iso-energetic diets differing in fat quantity and quality
on ex vivo whole blood culture (WBC) cytokine production accord-
ing to APOE genotype. The WBC technique measures cytokine pro-
duction following a pro-inﬂammatory stimulant and is considered
a more physiologically meaningful and informative measure of
inﬂammatory status in humans relative to the more traditional
assessment of plasma cytokines in fasting blood.2. Material and methods
2.1. Subjects and study design
A subset of the normolipidaemic participants from the SATgene
study (n = 52/88), who were prospectively recruited according to
APOE genotype (n = 26 E3/E3 and n = 26 E3/E4) provided blood
samples at the beginning of the study (baseline) and eight weeks
after the low fat (LF), high saturated fat (HSF) and HSF with
3.45 g/day DHA (HSF-DHA) diet for the determination of ex vivo
cytokine production using whole blood culture. The target macro-
nutrient composition of the diets are shown in Table 1 and a de-
tailed description of study design and dietary manipulation are
presented in Carvalho-Wells et al. [9].
2.2. Stimulation of whole blood cultures
Blood samples collected in EDTA tubes were diluted 1:9 with
RPMI 1640 medium (Sigma, UK) supplemented with 1% antibiotics,
1% L-glutamine and 1% non-essential amino acids (BioScience, UK).
Subsequently, the diluted blood sample was cultured in 12-well
plates (Greiner bio-one, UK), with 10 or 0.5 lg/ml of bacterial lipo-
polysaccharide (LPS) (E. coli 026:B6, Sigma, UK), leading to a ﬁnal
concentration of 1 or 0.05 lg/ml, respectively. Cultures were incu-
bated at 37 C for 24 h before centrifugation at 700g to isolate the
supernatant, which was stored at 20 C until analysis. The mono-
cyte count of each sample was measured by the Pathology Depart-
ment at the Royal Berkshire Hospital in Reading.
2.3. Measurement of the cytokine concentration using the Luminex
method
A Human Cytokine 10-Plex Panel (IL-1b, IL-2, IL-4, IL-5, IL-6, IL-
8, IL-10, IFN-c, TNF-a, and GM-CSF; Invitrogen, Life Technologies)Table 1
Target daily macronutrient composition of the 3 isoenergetic diets.
Target macronutrient composition LF diet HSF diet HSF-DHA diet
Energy from fat (%) 24 38 38
SFA (%) 8 18 18
MUFA (%) 8 12 12
PUFA (%) 6 6 6
Energy from carbohydrates (%) 59 45 45
Abbreviations: LF, low fat diet; HSF, high saturated fat diet; HSF-DHA, high saturated
fat diet with 3.45 g/d docosahexaenoic acid (DHA); SFA, saturated fat; MUFA,
monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; %, % of the total
energy intake.was used to measure the concentration of cytokines in the whole
blood culture supernatant using the Luminex 200. Only IL-1b,
IL-6, IL-8, IL-10 and TNF-a were detectable in the whole blood
culture samples. Cytokine production was expressed as lg/103
monocytes as previously reported by Nagata et al. [10] and
Rohleder et al. [11].2.4. Statistical analysis
A one-within, one-between repeated measures ANOVA was
used to analyse the effects of the different diets on the whole blood
culture cytokine concentrations in the two genotype groups. Loga-
rithmic or square-root transformation was applied to the variables
that were not normally distributed. When statistical differences
were found, data were further tested by the least signiﬁcant differ-
ence (LSD) post hoc test. The statistical analysis was performed
using SPSS version 17.0 (Statistical Package for Social Sciences,
SPSS Inc., Chicago, Illinois, USA). P 6 0.05 was considered statisti-
cally signiﬁcant.3. Results
Two subjects (APOE4 carriers) were excluded because of miss-
ing monocyte population data. Cytokine production by either
0.05 lg/ml or 1 lg/ml LPS-stimulated WBC was not signiﬁcantly
affected by genotype (Table 2, Fig. 1). In the data for the two geno-
type groups combined, dietary fat manipulation signiﬁcantly
affected TNF-a and IL-10 production, for both 0.05 lg/ml
(P = 0.012 and P = 0.036, respectively, repeated measures ANOVA)
and 1 lg/ml of LPS (P = 0.006 and P = 0.049, respectively, repeated
measures ANOVA) (Fig. 1). Post hoc analysis revealed that TNF-a
production was signiﬁcantly higher in the WBC supernatant after
the subjects consumed the HSF diet compared with baseline
(P = 0.004 and P = 0.002, for 0.05 and 1 lg/ml LPS, respectively)
and the LF diet (P = 0.020, for 1 lg/ml LPS only) (Fig. 1). The
HSF-DHA diet resulted in higher TNF-a concentration in compari-
son to baseline (P = 0.012 and P = 0.021, for 0.05 and 1 lg/ml LPS,
respectively) (Fig. 1). For both LPS concentrations, the consumption
of the LF diet resulted in signiﬁcantly higher concentrations of
IL-10, compared with baseline (P = 0.013 and P = 0.015, for 0.05
and 1 lg/ml LPS, respectively) and the HSF-DHA diet (P = 0.026
and P = 0.050, for 0.05 and 1 lg/ml LPS, respectively) (Fig. 1). The
levels of IL-1b, IL-6 and IL-8 were not signiﬁcantly modulated by
dietary fat composition (Table 2).4. Discussion
The present study investigated the impact of APOE genotype
on the ex vivo cytokine response of normolipidaemic subjects
to chronic dietary fat manipulation. It has been indicated that
APOE has immuno-modulatory properties that could affect the
risk of CVD [2]. APOE genotype has been reported to affect
macrophage cytokine secretion [1,2] and, thus, may be predicted
to inﬂuence inﬂammatory responses. As we previously reviewed
[2] animal and cell culture models and limited human study
evidence showed that pro-inﬂammatory cytokine levels, such
as TNF-a and IL-6, were higher whereas the anti-inﬂammatory
cytokine IL-10 concentrations were lower in APOE4-expressing
cells or genotype groups compared to APOE3 homozygotes. In
contrast, in the current study, cytokine production was not
signiﬁcantly affected by APOE genotype suggesting that in
normolipidaemic adults APOE genotype may not be a signiﬁcant
determinant of the circulating pro-inﬂammatory cytokine status
[2].
Table 2
Effect of dietary fat manipulation and genotype on cytokine production (lg per 103 monocytes) following stimulation of whole blood cultures with 0.05 and 1 lg/ml
lipopolysaccharide for 24 h.
Cytokine Baseline LF diet HSF diet HSF-DHA diet ANOVA
Mean SEM Mean SEM Mean SEM Mean SEM Diet (P value) Genotype (P value) Diet x genotype (P value)
0.05 lg/ml LPS
IL-1b 0.100 0.217 0.652
E3/E3 9.49 0.97 12.96 1.45 11.75 1.22 11.43 1.71
E3/E4 9.43 1.18 9.91 1.26 10.31 1.21 8.72 1.31
All 9.46 0.75 11.50 0.98 11.06 0.86 10.13 1.09
IL-6 0.162 0.091 0.492
E3/E3 51.1 5.3 77.2 13.2 61.0 6.5 55.4 7.7
E3/E4 46.5 6.0 46.5 4.1 49.9 6.0 49.3 8.1
All 48.9 4.0 62.5 7.4 55.7 4.5 52.5 5.5
IL-8 0.089 0.782 0.717
E3/E3 378.7 63.5 434.5 49.4 460.5 60.6 335.9 42.9
E3/E4 382.4 69.6 475.3 60.9 374.6 64.0 360.3 56.1
All 380.5 46.5 454.1 38.6 419.3 44.0 347.6 34.6
1 lg/ml LPS
IL-1b 0.084 0.299 0.607
E3/E3 13.68 1.16 16.13 1.61 15.55 1.58 15.28 2.32
E3/E4 12.00 1.44 13.38 1.47 15.81 1.81 12.39 1.71
All 12.87 0.91 14.81 1.10 15.68 1.18 13.89 1.46
IL-6 0.139 0.115 0.734
E3/E3 105.1 13.6 100.4 13.0 122.4 18.5 124.8 29.9
E3/E4 74.0 11.1 68.7 6.1 116.2 21.1 91.4 14.9
All 90.2 9.1 85.2 7.6 119.4 13.9 108.8 17.1
IL-8 0.278 0.983 0.191
E3/E3 592.2 81.4 534.5 66.7 1099.1 520.9 465.2 74.1
E3/E4 469.1 58.5 698.3 86.0 566 60.7 658.1 163.9
All 533.1 51.1 613.2 54.6 843.2 272.5 557.8 87.7
Values represent mean SEM for the data presented according to genotype (E3/E3, n = 26 and E3/E4, n = 24) and the genotype groups combined (All, n = 50). Abbreviations: LPS,
lipopolysaccharide; LF, low fat diet; HSF, high saturated fat diet; HSF-DHA, high saturated fat diet with 3.45 g/d docosahexaenoic acid (DHA).
Fig. 1. Effect of dietary fat manipulation and genotype on TNF-a and IL-10 production (lg per 103 monocytes) following stimulation of whole blood cultures with (A) 0.05 lg/
ml and (B) 1 lg/ml of lipopolysaccharide (LPS) for 24 h. Values are means for all the subjects (black bars, n = 50), E3/E3 (white bars, n = 26), E3/E4 (grey bars, n = 24), with their
standard errors represented by vertical bars. An overall diet effect was evident for TNF-a (P = 0.012, 0.006) and IL-10 (P = 0.036, 0.049) at 0.05 and 1 lg/ml of LPS respectively,
when the genotype groups were combined (n = 50). a,b,c Mean values with unlike superscript letters were signiﬁcantly different (P 6 0.05), after a post hoc analysis.
Abbreviations: LF, low fat diet; HSF, high saturated fat diet, HSF-DHA, HSF diet with 3.45 g/d of docosahexaenoic acid.
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the impact of a high fat diet, as well as high SFA diet, on
pro-inﬂammatory markers [5–8]. Nappo et al. [7] have reported
that a high fat meal (59% fat) increased the postprandial levels of
TNF-a, IL-6, intercellular adhesion molecule-1 (ICAM-1) and
vascular cell adhesion molecule-1 (VCAM-1) in normal subjects,
whereas an isoenergetic high carbohydrate meal had no effect.
Longer-term dietary studies have also reported a signiﬁcant effect
of dietary fat manipulation on the inﬂammatory response. Baer
et al. [8] have shown that the consumption of speciﬁc saturated
fatty acids including lauric, myristic, palmitic and stearic acid for
a ﬁve-week period was associated with higher levels of CRP, ﬁbrin-
ogen and IL-6. These results are in agreement with our data, where
TNF-a, an important pro-inﬂammatory cytokine involved in the
progression of atherosclerosis, signiﬁcantly increased after con-
sumption of a diet high in SFA (HSF). Previous analysis of our data
has also shown that the HSF diet resulted in a signiﬁcant increase
in fasted serum CRP, compared with the LF diet [9]. These data sug-
gests that the deleterious impact of habitual high fat and high sat-
urated fat intake may in part be mediated via an impact on TNF-a
production.
Consumption of the LF diet was associated with a signiﬁcant in-
crease in IL-10 concentrations compared with the baseline. IL-10 is
an anti-inﬂammatory cytokine, which down-regulates many
inﬂammatory pathways that are associated with atherosclerosis
[12]. In particular, it inhibits the production of NF-jB and thus,
suppresses cytokine production [12]. Moreover, it is associated
with beneﬁcial effects in patients with acute coronary disease
[13]. To the best of our knowledge, this study is among the ﬁrst
to evaluate the effect of different iso-energetic fat diets on the
ex vivo levels of an anti-inﬂammatory cytokine, such as IL-10 in
WBC samples obtained from human subjects. With reference to
the supplementation of the HSF diet with long chain n-3 fatty acids
(3.45 g/d of DHA) we did not observe any signiﬁcant changes in
cytokine levels between APOE3/E3 and APOE4 carriers nor in our
study group as a whole. Although long-chain n-3 fatty acids are
purported to be anti-inﬂammatory, with for example demon-
strated beneﬁts on plaque inﬂammation [14] and the need for
use of non-steroidal anti-inﬂammatory drugs in rheumatoid arthri-
tis patients [15], our results are in general agreement with the
majority of human intervention studies, including our main SAT-
gene study, which have not shown a clear effect on circulating
inﬂammatory status [16].
In this study two concentrations of LPS were used for stimula-
tion of WBC (1 lg/ml and 0.05 lg/ml) with both giving comparable
results. It is therefore suggested that in future studies it would be
advisable to use the more physiological concentration of 0.05 lg/
ml. Moreover, since monocytes are the main site of cytokine pro-
duction after LPS stimulation in whole blood, a correction with
monocytes is considered by many to be the most appropriate
method to use [10,11].
In conclusion, dietary fat composition but not APOE genotype
signiﬁcantly inﬂuenced ex vivo pro- and anti-inﬂammatorycytokine production after LPS stimulation of WBC samples ob-
tained from normolipidaemic adults.Acknowledgements
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